Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-25, Stock:JNJ, The news for the past five days is as follows:
2019-10-18: NEWS1: US Stocks Decline Friday.NEWS2: US Indexes Close Lower Friday After Weak China Data Report.NEWS3: J&J Recalls Lot of Baby Powder After Asbestos Trace Found.NEWS4: Stocks - S&P Knocked Down by Boeing, JNJ, China.NEWS5: [video]Game Plan for Earnings: Cramer's 'Mad Money' Recap (Friday 10/18/19).NEWS6: Boeing and JNJ Drag Dow Lower, End Week in Red.NEWS7: J&J Stock Plunges After FDA Test Finds Asbestos In Baby Powder.NEWS8: US STOCKS-Boeing, J&J, dismal China data drag Wall Street lower.NEWS9: US STOCKS SNAPSHOT-Boeing, J&J pull down Wall Street along with weak China data.NEWS10: 5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP.NEWS11: Johnson & Johnson recalls baby powder, the subject of a $4.7 billion St. Louis verdict.NEWS12: Bad Day On Stock Market Continues; These Two Stocks Took Down The Dow.NEWS13: Boeing, Johnson & Johnson share losses lead Dow's 200-point drop.NEWS14: US STOCKS-Wall Street weighed by Boeing, J&J, bleak China data.NEWS15: FDA alerts consumers of J&J baby powder recall, says it stands by tests.NEWS16: Boeing's stock selloff a triple-digit point drag on the Dow.NEWS17: US STOCKS-Wall St pressured by J&J, Boeing; growth worries linger.NEWS18: Tech Stocks Lead Selling As Boeing, J&J Hit The Dow Jones Industrial Average.NEWS19: Johnson & Johnson Stock Falls on Baby Powder Recall.NEWS20: Jim Cramer: Johnson & Johnson's Baby Powder Recall Is 'Suboptimal'.NEWS21: UPDATE 4-Opioid settlement talks falter, landmark trial expected Monday -attorney.NEWS22: Dow industrials skid 200 points lower in midday action as J&J and Boeing's stock produce 100-point headwind.NEWS23: US STOCKS-Wall Street pressured by J&J, global growth concerns.NEWS24: Johnson & Johnson, Boeing share losses lead Dow's 139-point fall.NEWS25: Stock Market Extends Losses, But These 2 Dow Stocks Are Near Buy Points.NEWS26: The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Pfizer, Qualcomm and Mitsubishi UFJ Financial.NEWS27: 3 Medical Product Stocks Likely to Beat This Earnings Season.NEWS28: Arrowhead Pharmaceuticals Is Flying Higher on the Charts.NEWS29: Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow.NEWS30: Options Bears Blast Johnson & Johnson After Baby Powder Recall.NEWS31: For Boeing and Johnson & Johnson: Where There's Smoke, There's Fire.NEWS32: US STOCKS-Wall St treads water as earnings counter China data gloom; J&J falls.NEWS33: Dow Jones Falls In Weak Stock Market Action; Intuitive Surgical Is Breaking Out Today.NEWS34: It’s Crunch Time for an Opioid Settlement Before Key Trial Starts.NEWS35: Johnson & Johnson, American Express share losses lead Dow's 70-point fall.NEWS36: Settling Opioid Suits Probably Won’t End the Crisis.NEWS37: Dow breaks slightly lower at Friday's open as J&J's stock weighs on blue chips.NEWS38: US STOCKS SNAPSHOT-Wall St opens lower as J&J slips.NEWS39: Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder.NEWS40: Johnson & Johnson's stock drops after baby powder recall.NEWS41: Johnson & Johnson to recall some baby powder as FDA finds traces of asbestos.NEWS42: Johnson & Johnson Consumer Inc. To Voluntarily Recall A Single Lot Of Johnson's Baby Powder In The United States.NEWS43: UPDATE 3-WHO hails 'triumph' as Merck's Ebola vaccine gets European green light.NEWS44: J&J's depression drug Spravato wins European panel vote.NEWS45: The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe.NEWS46: J&J recalls batch of baby powder after asbestos traces found.NEWS47: UPDATE 1-Judge summons drug company CEOs to discuss opioid settlement - source.
2019-10-21: NEWS1: October brings losses for short sellers in U.S. opioid-related shares.NEWS2: Shapiro, state AGs announce tentative $48B national opioid settlement.NEWS3: Drug Companies Strike $48 Billion Deal In Opioid Crisis With Four States.NEWS4: How 16 Blue Chip Stocks Are Getting Squeezed by Strong Dollar.NEWS5: Get Real. There Will Be a Global Opioid Settlement..NEWS6: J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos.NEWS7: Opioid settlement reached with four drug companies: report.NEWS8: How Much Litigation Risk Is Priced Into Johnson & Johnson?.NEWS9: Four companies reach opioid settlement in Ohio.NEWS10: Stock Market News for Oct 21, 2019.NEWS11: McKesson Among Four to Pay Over $250 Million in Opioid Case.NEWS12: 4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain.NEWS13: There’s Still No Global Deal on Opioid Litigation, but Distributors Will Sit Out Monday Trial.NEWS14: UPDATE 9-Drug firms avert landmark opioid trial as talks on $48-bln settlement set to resume.NEWS15: Johnson & Johnson stock pummeled after asbestos-related baby powder recall.NEWS16: Energy Stocks Are Getting Hammered.NEWS17: 5 Stocks Set to Lead Longterm as Fed Rate Cuts Deepen.
2019-10-22: NEWS1: Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell.NEWS2: Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell.NEWS3: 7 Safe Stocks to Buy and Hold Through 2020.NEWS4: Drug/Biotech Stock Q3 Earnings on Oct 23: LLY, ALXN & More.NEWS5: Medical Products' Earnings Roster for Oct 23: TMO, BSX & More.NEWS6: Drug companies eye deals as lawsuits pile up.NEWS7: Biogen (BIIB) Beats on Q3 Earnings, Eyes FDA Nod for Aducanumab.
2019-10-23: NEWS1: UPDATE 1-J&J slashes third-quarter profit by $3 bln over proposed opioid deal.NEWS2: Johnson & Johnson restates earnings over opioid settlement.NEWS3: J&J slashes third-quarter profit by $3 billion over proposed opioid deal.NEWS4: J&J says proposed opioid settlement to lower reported Q3 profit by $3 bln.NEWS5: 2 Sells and 1 Buy in Opioid Stocks.NEWS6: Johnson & Johnson Confirms $4 billion 'Agreement in Principle' Opioid Settlement.NEWS7: Is the Worst Over for Johnson & Johnson?.NEWS8: Does Johnson & Johnson (NYSE:JNJ) Have A Healthy Balance Sheet?.NEWS9: J&J Recalls Baby Powder After Asbestos Find — Is JNJ Stock A Safe Buy?.NEWS10: Health-Care Stocks Gain as Elizabeth Warren’s Victory Looks Less Assured.
2019-10-24: NEWS1: CORRECTED-US STOCKS-Strong tech results propel S&P 500, Nasdaq.NEWS2: UPDATE 7-Big U.S. retailers pull 22-ounce J&J baby powder off shelves after recall.NEWS3: 3M, Cisco share losses lead the way, but Dow flat.NEWS4: Johnson & Johnson -- Moody's: J&J's proposed opioid agreement credit negative.NEWS5: Johnson & Johnson Cut Its Earnings in a Late-Night Filing. Here’s Why..NEWS6: Alkermes' (ALKS) Earnings and Sales Beat Estimates in Q3.NEWS7: Several states wary of $48 billion opioid settlement proposal.

Answer: Rise